Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Nature Chemical Biology|December 19, 2017
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradationCalla M Olson, Baishan Jiang, Michael A Erb, et al.ACS Chemical Biology|May 26, 2016
Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in VivoThomas B Sundberg, Yanke Liang, Huixian Wu, et al.Nature Communications|July 27, 2022
Targeting transcription in heart failure via CDK7/12/13 inhibitionAustin Hsu, Qiming Duan, Daniel S Day, et al.Cell Chemical Biology|March 26, 2019
Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle PhenotypeCalla M Olson, Yanke Liang, Alan Leggett, et al.Nature Chemical Biology|August 30, 2016
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitorsTinghu Zhang, Nicholas Kwiatkowski, Calla M Olson, et al.Elife|November 14, 2018
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13Mei Zeng, Nicholas P Kwiatkowski, Tinghu Zhang, et al.ACS Chemical Biology|February 22, 2014
Discovery of a potent, covalent BTK inhibitor for B-cell lymphomaHong Wu, Wenchao Wang, Feiyang Liu, et al.Nature Communications|October 20, 2019
A kinase-independent role for CDK8 in BCR-ABL1+ leukemiaIngeborg Menzl, Tinghu Zhang, Angelika Berger-Becvar, et al.Nature Communications|October 21, 2016
SIKs control osteocyte responses to parathyroid hormoneMarc N Wein, Yanke Liang, Olga Goransson, et al.Cancer Research|October 28, 2025
CFT1946 is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader that Overcomes BRAF Inhibitor ResistanceBridget T Kreger, Yanke Liang, Nicole M Reilly, et al.Pageof 3